Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
about
Review of IL-17 inhibitors for psoriasis.Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?A systematic review of active comparator controlled clinical trials in patients with moderate-to-severe psoriasis.Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
P2860
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@en
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@nl
type
label
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@en
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@nl
prefLabel
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@en
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@nl
P2093
P2860
P921
P1476
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
@en
P2093
Elias Oussedik
Leah A Cardwell
Megan Hohenberger
Steven R Feldman
P2860
P356
10.1080/09546634.2017.1329511
P577
2017-05-18T00:00:00Z